Skip to content
LIVE MARKETS
--:--:--
ET
Testsite
Thoughts, stories and ideas.
40 filings/day — zero noise
Today's
stories · chronological wire
Search the wire
⌘K
Sign in
Subscribe
Home
LTGO
LTGO
1 story on the wire
LTGO
1 filing
Chronological · ET
10:52
LTGO
LATIGO Posts First Results Since $397M IPO, Phase 3 Set for Late 2026
Latigo Biotherapeutics reported a $25.8 million second-quarter loss and said IPO proceeds fund operations into 2029 as onzotrigine heads to Phase 3.
Earnings
Sep 4
8 days ago
PRO
No filings match.
Try another ticker or clear the filter.
LOAD EARLIER